Bone loss and glucocorticoid therapy in patients with respiratory disease.
Fairney
A
A
Department of Endocrinology and Metabolic Medicine, Imperial College School of Medicine, St Mary's Hospital, Paddington, London, UK.
D019386:Alendronate / Q000627:therapeutic use; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000517:prevention & control; D012120:Respiration Disorders / Q000188:drug therapy*
D005938:Glucocorticoids; D019386:Alendronate